Frequently purchased
Multiple Sclerosis Drugs Intelligence License
US $1,950
One thousand nine hundred fifty
- Everything in Single Drug Intelligence License
- Comprehensive intelligence of 20 drugs
- Report accessible by 1 user only
- Intelligence covering all marketed and pipeline drugs within one indication
- Drug-by-drug commercial assessment
- Market sizing and forecasts by therapy
- Epidemiology overview
- Competitive landscape and market share analysis across Indication
- Personalized analyst briefing session
- Biannually intelligence update
- Excel database access
- Dedicated account manager
- Priority analyst support